The costs and benefits of regulations for reimbursement of new drugs
Year of publication: |
2006
|
---|---|
Authors: | Lundkvist, Jonas ; Jonsson, Bengt ; Rehnberg, Clas |
Published in: |
Health Policy. - Elsevier, ISSN 0168-8510. - Vol. 79.2006, 2-3, p. 337-344
|
Publisher: |
Elsevier |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
The economic and quality of life impact of hypoglycemia
Lundkvist, Jonas, (2005)
-
Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden
Lundkvist, Jonas, (2003)
-
Jönsson, Bengt, (2002)
- More ...